Fairtree Asset Management Pty Ltd Takes Position in Ventas, Inc. $VTR

Fairtree Asset Management Pty Ltd purchased a new position in Ventas, Inc. (NYSE:VTR) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 10,719 shares of the real estate investment trust’s stock, valued at approximately $952,000.

A number of other hedge funds also recently bought and sold shares of the company. Dynamic Wealth Strategies LLC purchased a new stake in shares of Ventas during the 1st quarter valued at about $25,000. Wiser Advisor Group LLC bought a new stake in Ventas during the third quarter valued at approximately $27,000. Meeder Asset Management Inc. purchased a new stake in Ventas during the second quarter valued at approximately $30,000. IFC & Insurance Marketing Inc. purchased a new stake in Ventas during the fourth quarter valued at approximately $30,000. Finally, Elyxium Wealth LLC bought a new position in Ventas in the fourth quarter worth approximately $33,000. Hedge funds and other institutional investors own 94.18% of the company’s stock.

Analyst Ratings Changes

Several research analysts have recently weighed in on VTR shares. Jefferies Financial Group lifted their price target on shares of Ventas from $97.00 to $100.00 and gave the stock a “buy” rating in a research note on Tuesday, May 12th. Scotiabank reduced their price objective on Ventas from $95.00 to $88.00 and set a “sector perform” rating for the company in a research note on Thursday, June 18th. UBS Group raised their target price on Ventas from $85.00 to $93.00 and gave the stock a “neutral” rating in a report on Monday, May 4th. BMO Capital Markets lifted their target price on Ventas from $105.00 to $107.00 and gave the company an “outperform” rating in a research report on Tuesday, August 11th. Finally, JPMorgan Chase & Co. boosted their price target on Ventas from $93.00 to $94.00 and gave the company an “overweight” rating in a report on Monday, May 11th. Fifteen investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat.com, Ventas presently has a consensus rating of “Moderate Buy” and a consensus price target of $98.00.

Ventas Price Performance

Shares of NYSE:VTR opened at $92.82 on Friday. The company has a market capitalization of $47.61 billion, a P/E ratio of 171.89, a P/E/G ratio of 2.12 and a beta of 0.69. Ventas, Inc. has a 1-year low of $66.38 and a 1-year high of $101.60. The firm’s 50 day simple moving average is $91.18 and its two-hundred day simple moving average is $87.04. The company has a debt-to-equity ratio of 0.86, a current ratio of 0.44 and a quick ratio of 0.44.

Ventas (NYSE:VTR) last announced its quarterly earnings data on Wednesday, July 29th. The real estate investment trust reported $0.97 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.96 by $0.01. The firm had revenue of $1.73 billion during the quarter, compared to analysts’ expectations of $1.68 billion. Ventas had a net margin of 4.08% and a return on equity of 1.99%. The company’s revenue for the quarter was up 21.7% compared to the same quarter last year. During the same period in the prior year, the company posted $0.87 earnings per share. Research analysts expect that Ventas, Inc. will post 3.89 EPS for the current fiscal year.

Insiders Place Their Bets

In other Ventas news, Director Michael J. Embler purchased 2,500 shares of the business’s stock in a transaction on Wednesday, June 3rd. The stock was acquired at an average price of $78.81 per share, for a total transaction of $197,025.00. Following the purchase, the director owned 19,202 shares of the company’s stock, valued at approximately $1,513,309.62. This represents a 14.97% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Corporate insiders own 0.53% of the company’s stock.

Ventas Profile

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.